Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health
August 16, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health...
Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And Research Centre
July 13, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company cultivating and...
Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA
June 28, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 28, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics
June 20, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 20, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Psychedelic Media Company Tripsitter.com Announces Refresh for 2022 — Features Over 100 Psychedelic Monographs
May 03, 2022 21:00 ET
|
Tripsitter
NEW YORK, May 03, 2022 (GLOBE NEWSWIRE) -- Tripsitter (tripsitter.com) is an educational resource and advocate for the responsible use of psychedelics. The site features over 100 psychedelic...
Clearmind Medicine Files Provisional Patent Application Related to Methods of Drug-Assisted Psychotherapy
October 13, 2021 08:00 ET
|
Clearmind Medicine
TORONTO, Ontario, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
InvestorBrandNetwork (IBN) and PsychedelicNewsWire (PNW) Announce Collaboration with Microdose Psychedelic Insights for the upcoming June Conferences
June 11, 2021 13:46 ET
|
InvestorBrandNetwork (IBN)
NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- via PsychedelicNewsWire -- InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, today announces that it will be...
MagicMed Industries to Present at the Q1 Virtual Investor Summit
March 19, 2021 08:15 ET
|
MagicMed Industries Inc.
CALGARY, Alberta, March 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- MagicMed Industries Inc. ("MagicMed" or the "Company"), a biotechnology company focused on creating novel psychedelic...
InvestorBrandNetwork Introduces PsychedelicNewsWire – A Technology Driven Communications Platform Focused on Emerging Market Opportunities in all Aspects of Psychedelics and Therapeutics
June 25, 2020 08:17 ET
|
InvestorBrandNetwork (IBN)
SAN FRANCISCO, June 25, 2020 (GLOBE NEWSWIRE) -- (June 25, 2020) – via NetworkWire – InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies...
MDMA Leader Mark Leahey to Speak at SEMDA 2013 Conference
December 20, 2012 08:25 ET
|
Southeastern Medical Device Association
ATLANTA, GA--(Marketwire - Dec 20, 2012) - Mark B. Leahey, President and CEO for the Medical Device Manufacturers Association (MDMA), will speak at the SEMDA 2013 Conference. MDMA is a national...